Bessemer Group’s Epizyme, Inc EPZM Stock Holding History

Bessemer Group’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,220	Closed	-$15K	–	1495
2016 Q1	$15K	Buy	+1,220	New	+$12.3K	﹤0.01%	1104

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Bessemer Group's EPZM Position: Q2 2016 in Review

Bessemer Group sold out of Epizyme, Inc (EPZM) in Q2 2016, closing a stake of 1,220 shares — an estimated $15K sold.

Bessemer Group first reported a position in EPZM in Q1 2016 and held it in 1 quarter. The position peaked at $15K in Q1 2016. 99 funds tracked by Wall St. Rank hold EPZM as of Q2 2016.

Bessemer Group reported no remaining Epizyme, Inc position as of Q2 2016 after selling out during the quarter.
Bessemer Group sold 1,220 Epizyme, Inc shares in Q2 2016, an estimated $15K.
Bessemer Group first reported a position in Epizyme, Inc in Q1 2016 and held it in 1 quarter.
Bessemer Group's Epizyme, Inc position peaked at $15K in Q1 2016.
99 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2016.

Based on Bessemer Group's 13F filing for Q2 2016, filed 11 Aug 2016.